Attention to the Unseen

Antibodies (white) binding to a coronavirus (red and orange). Kateryna Kon/Shutterstock By Sarah L Caddy, University of Cambridge and Meng Wang, University of Cambridge The emergence of “variants of concern” has raised questions about our long-term immunity to the coronavirus. Will the antibodies we make after being infected with or vaccinated against the dominant lineage, called D614G, protect us against future viral variants? To answer this question, scientists have been examining how our antibody responses to the coronavirus develop over…

Read More Read More

Tina Hesman Saey writes: It’s been two decades since the Human Genome Project first unveiled a rough draft of our genetic instruction book. The promise of that medical moon shot was that doctors would soon be able to look at an individual’s DNA and prescribe the right medicines for that person’s illness or even prevent certain diseases. That promise, known as precision medicine, has yet to be fulfilled in any widespread way. True, researchers are getting clues about some genetic…

Read More Read More

Meghan O’Rourke writes: The quest at mount sinai began with a mystery. During the first wave of the coronavirus pandemic in New York City, Zijian Chen, an endocrinologist, had been appointed medical director of the hospital’s new Center for Post-COVID Care, dedicated both to research and to helping recovering patients “transition from hospital to home,” as Mount Sinai put it. One day last spring, he turned to an online survey of COVID‑19 patients who were more than a month past…

Read More Read More

Hilda Bastian writes: Public-health officials are enthusiastic about the new, single-shot COVID-19 vaccine from Johnson & Johnson, despite its having a somewhat lower efficacy at preventing symptomatic illness than other available options. Although clinical-trial data peg that rate at 72 percent in the United States, compared with 94 and 95 percent for the Moderna and Pfizer-BioNTech vaccines, many experts say we shouldn’t fixate on those numbers. Much more germane, they say, is the fact that the Johnson & Johnson shot,…

Read More Read More

Dhruv Khullar writes: Last March, during the first wave of the pandemic, Adriana Heguy set out to sequence coronavirus genomes. At the time, New York City’s hospitals were filling up, and American testing capacity was abysmal; the focus was on increasing testing, to figure out who had the virus and who didn’t. But Heguy, the director of the Genome Technology Center at N.Y.U. Langone Health, recognized that diagnostic tests weren’t enough. Tracking mutations in the virus’s genetic code would be…

Read More Read More

Andrew Joseph and Helen Branswell write: When experts envision the future of the coronavirus, many predict that it will become a seasonal pathogen that won’t be much more than a nuisance for most of us who have been vaccinated or previously exposed to it. But how long that process takes — and how much damage the virus inflicts in the interim — is still anyone’s guess. “The most predictable thing about this coronavirus is its unpredictability,” said Howard Markel, a…

Read More Read More

Tara C. Smith writes: Viruses evolve. It’s what they do. That’s especially true for a pandemic virus like SARS-CoV-2, the one behind COVID-19. When a population lacks immunity and transmission is extensive, we expect viral mutations to appear frequently simply due to the number of viruses replicating in a short period of time. And the growing presence of immune individuals means that the viruses that can still transmit in these partially immune populations will be favored over the original version….

Read More Read More

Nature reports: An enormous international database launched today will help epidemiologists to answer burning questions about the coronavirus SARS-CoV-2, such as how rapidly new variants spread among people, whether vaccines protect against them and how long immunity to COVID-19 lasts. Unlike the global COVID-19 dashboard maintained by Johns Hopkins University in Baltimore, Maryland, and other popular trackers that list overall COVID-19 infections and deaths, the new repository at the data-science initiative called Global.health collects an unprecedented amount of anonymized information…

Read More Read More

The Los Angeles Times reports: A coronavirus variant that emerged in mid-2020 and surged to become the dominant strain in California not only spreads more readily than its predecessors, but also evades antibodies generated by COVID-19 vaccines or prior infection and is associated with severe illness and death, researchers said. In a study that helps explain the state’s dramatic surge in COVID-19 cases and deaths — and portends further trouble ahead — scientists at UC San Francisco said the cluster…

Read More Read More

By Dominic Dwyer, University of Sydney As I write, I am in hotel quarantine in Sydney, after returning from Wuhan, China. There, I was the Australian representative on the international World Health Organization’s (WHO) investigation into the origins of the SARS-CoV-2 virus. Much has been said of the politics surrounding the mission to investigate the viral origins of COVID-19. So it’s easy to forget that behind these investigations are real people. As part of the mission, we met the man…

Read More Read More

Katherine J. Wu writes: To locate some of the world’s most superpowered cells, look no further than the human immune system. The mission of these hometown heroes is threefold: Memorize the features of dangerous microbes that breach the body’s barriers. Launch an attack to bring them to heel. Then squirrel away intel to quash future assaults. The immune system is comprehensive, capable of dueling with just about every microbe it meets. It’s archival, ace at memorizing the details of its…

Read More Read More

Matt Reynolds writes: In each warm body it infects, the virus behind Covid-19 has the potential to change. It can become more deadly, more transmissible or more resistant to the vaccines on which we are all pinning so much hope. Mercifully, the biology of Sars-CoV-2 means that such changes happen slowly and almost always fail to catch on. But mutations, like pandemics, are a numbers game. Every new person infected provides another opportunity for the virus to adopt a new…

Read More Read More